93 64 Pill - yellow round
Pill with imprint 93 64 is Yellow, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Teva Pharmaceuticals USA Inc.
Rabeprazole is used in the treatment of Barrett's Esophagus; Erosive Esophagitis; Duodenal Ulcer; Duodenal Ulcer Prophylaxis; GERD and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 64
Rabeprazole Sodium Delayed-Release
- Imprint
- 93 64
- Strength
- 20 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Proton pump inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc.
- Inactive Ingredients
-
D&C Yellow No. 10,
FD&C Yellow No. 6,
hydroxypropyl cellulose,
hypromelloses,
hypromellose 2910 (15 mPa.s),
hypromellose phthalate (31% phthalate, 40 cst),
ferrosoferric oxide,
lactose monohydrate,
low substituted hydroxypropyl cellulose,
magnesium oxide,
magnesium stearate,
mannitol,
microcrystalline cellulose,
polyethylene glycol 4000,
propylene glycol,
shellac,
stearic acid,
titanium dioxide,
triethyl citrate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-0064 (Discontinued) | Teva Pharmaceuticals USA, Inc. |
| 42291-0721 (Discontinued) | AvKare, Inc. |
Related images for "93 64"
More about rabeprazole
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (85)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: proton pump inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
